The price of Clorox Co. (NYSE: CLX) closed at $150.49 in the last session, down -2.02% from day before closing price of $153.59. In other words, the price has decreased by -$3.10 from its previous closing price. On the day, 1372862 shares were traded.
Ratios:
We take a closer look at CLX’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 52.61 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 25.66. For the most recent quarter (mrq), Quick Ratio is recorded 0.57 and its Current Ratio is at 0.89. In the meantime, Its Debt-to-Equity ratio is 59.04 whereas as Long-Term Debt/Eq ratio is at 52.64.
On February 05, 2024, DA Davidson Downgraded its rating to Neutral which previously was Buy but kept the price unchanged to $162.
BofA Securities Upgraded its Underperform to Neutral on December 15, 2023, whereas the target price for the stock was revised from $120 to $150.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 14 ’23 when Jacobsen Kevin B sold 3,346 shares for $160.82 per share. The transaction valued at 538,096 led to the insider holds 23,224 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLX now has a Market Capitalization of 18.68B and an Enterprise Value of 21.45B. As of this moment, Clorox’s Price-to-Earnings (P/E) ratio for their current fiscal year is 236.51, and their Forward P/E ratio for the next fiscal year is 23.30. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 19.69. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.56 while its Price-to-Book (P/B) ratio in mrq is 352.32. Its current Enterprise Value per Revenue stands at 2.93 whereas that against EBITDA is 43.87.
Stock Price History:
Over the past 52 weeks, CLX has reached a high of $178.21, while it has fallen to a 52-week low of $114.68. The 50-Day Moving Average of the stock is 149.78, while the 200-Day Moving Average is calculated to be 145.79.
Shares Statistics:
According to the various share statistics, CLX traded on average about 1.17M shares per day over the past 3-months and 1.17M shares per day over the past 10 days. A total of 124.11M shares are outstanding, with a floating share count of 123.84M. Insiders hold about 0.21% of the company’s shares, while institutions hold 80.71% stake in the company. Shares short for CLX as of Feb 29, 2024 were 4.08M with a Short Ratio of 3.47, compared to 4.28M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.29% and a Short% of Float of 3.75%.
Dividends & Splits
The forward annual dividend rate for CLX is 4.78, which was 4.78 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 3.11%, it implies a Forward Annual Dividend Yield of 3.19%. The stock’s 5-year Average Dividend Yield is 2.76. The current Payout Ratio is 395.03% for CLX, which recently paid a dividend on May 10, 2024 with an ex-dividend date of Apr 23, 2024. Stock splits for the company last occurred on Aug 24, 1999 when the company split stock in a 2:1 ratio.
Earnings Estimates
The company has 14 analysts who recommend its stock at the moment. On average, analysts expect EPS of $1.45 for the current quarter, with a high estimate of $1.87 and a low estimate of $1.32, while EPS last year was $1.51. The consensus estimate for the next quarter is $1.55, with high estimates of $1.78 and low estimates of $1.42.
Analysts are recommending an EPS of between $6.21 and $5.4 for the fiscal current year, implying an average EPS of $5.65. EPS for the following year is $6.5, with 17 analysts recommending between $7 and $5.59.
Revenue Estimates
A total of 15 analysts have provided revenue estimates for CLX’s current fiscal year. The highest revenue estimate was $7.46B, while the lowest revenue estimate was $7.15B, resulting in an average revenue estimate of $7.28B. In the same quarter a year ago, actual revenue was $7.39B, down -1.40% from the average estimate. Based on 17 analysts’ estimates, the company’s revenue will be $7.58B in the next fiscal year. The high estimate is $7.74B and the low estimate is $7.31B. The average revenue growth estimate for next year is up 4.00% from the average revenue estimate for this year.
